- About Us
- Media Release
- Our Clients
- Media Mentions
- Subscription Model
- Contact Us
The Europe Carrier Screening Market would witness market growth of 12.95% CAGR during the forecast period (2021-2027).
The carrier screening market would witness lucrative growth opportunities due to the rise in importance of early disease detection and prevention, increasing demand for personalized medicine, and rising applications of screening tests in genetic disorders, which would open new growth avenues for the overall carrier screening market during the forecast period.
The increasing popularity of smart healthcare procedures is driving the growth of the carrier screening market. In addition, the growing cases of many genetic diseases and other diseases that occur due to the errors in genetic codes in various nations of this region will also contribute to the increasing demand for carrier screening in the region. The population across this region is more aware of maintaining a healthy lifestyle along with getting a regular checkup, for which they are highly adopting procedures that can detect the abnormalities in their genes in order to prevent themselves from any disease in the future.
Due to carrier screening procedures, the individuals get to know about the defects in their genetic codes, thereby creating awareness regarding different diseases related to genes. All such factors are collaboratively working to boost the demand and growth for the carrier screening market in the regional market.
Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The End-user segment is likely to showcase a similar kind of trend even during the forecast period. Factors such as the growing occurrence of genetic disorders and developments in carrier screening are likely to propel the growth of this segment.
The Germany market dominated the Europe Carrier Screening Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $149.2 million by 2027. The UK market is would experience a CAGR of 9.9% during (2021 - 2027). Additionally, The France market is exhibiting a CAGR of 12.4% during (2021 - 2027).
Free Valuable Insights: The Global Carrier Screening Market Size will Hit $2,501.94 Million by 2027, at a CAGR of 10.81%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.
By End User
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.